Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Yves Cahn

Showing results (11-20 of 168) with videos related to

Pageof 17
Sort By:
Environmental Science & Technology|May 2, 2006
Dispersion modeling as a dioxin exposure indicator in the vicinity of a municipal solid waste incinerator: a validation studyNathalie Floret, Jean-François Viel, Eric Lucot, et al.
Experimental Hematology|February 26, 2005
In vitro functional defects of bone marrow-derived CD34+ progenitors from newly diagnosed mature B-cell malignancies with bone marrow tumor involvementPatricia Amé-Thomas, Frédéric Deschaseaux, Frédéric Mauny, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2014
Alemtuzumab for severe steroid-refractory gastrointestinal acute graft-versus-host diseaseMathieu Meunier, Claude Eric Bulabois, Anne Thiebaut-Bertrand, et al.
Journal of Hematotherapy & Stem Cell Research|September 11, 2003
A single intravenous infusion of apoptotic cells, an alternative cell-based therapy approach facilitating hematopoietic cell engraftment, did not induce autoimmunitySylvain Perruche, François Kleinclauss, Régis Angonin, et al.
Fundamental & Clinical Pharmacology|October 12, 2018
Inflammation is a potential risk factor of voriconazole overdose in hematological patientsElodie Gautier-Veyret, Aurélie Truffot, Sébastien Bailly, et al.
Transplantation|November 20, 2002
Factor XIII replacement in stem-cell transplant recipients with severe hemorrhagic cystitis: a report of four casesKarine Demesmay, Edgar Tissot, Claude-Eric Bulabois, et al.
Experimental Hematology|October 8, 2008
Proteomic study of the impact of the JAK2-V617F mutation on the phenotype of essential thrombocythemiaPascal Mossuz, Marie Arlotto, Sylvie Hermouet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
Quantitating effector and regulatory T lymphocytes in immune responses by limiting dilution analysis modelingThierry Bonnefoix, Philippe Bonnefoix, Pascal Perron, et al.
Bulletin Du Cancer|August 29, 2006
[Cost of hospital-based management of acute myeloid leukemia: from analytical to procedure-based tarification]Philippe Fagnoni, Samuel Limat, Estelle Hintzy-Fein, et al.
Clinical Drug Investigation|May 30, 2007
Cost Effectiveness of Cardioprotective Strategies in Patients with Aggressive Non-Hodgkin's LymphomaSamuel Limat, Karine Demesmay, Philippe Fagnoni, et al.
Pageof 17

Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
Environmental Science & Technology|May 2, 2006
Dispersion modeling as a dioxin exposure indicator in the vicinity of a municipal solid waste incinerator: a validation studyNathalie Floret, Jean-François Viel, Eric Lucot, et al.
Experimental Hematology|February 26, 2005
In vitro functional defects of bone marrow-derived CD34+ progenitors from newly diagnosed mature B-cell malignancies with bone marrow tumor involvementPatricia Amé-Thomas, Frédéric Deschaseaux, Frédéric Mauny, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2014
Alemtuzumab for severe steroid-refractory gastrointestinal acute graft-versus-host diseaseMathieu Meunier, Claude Eric Bulabois, Anne Thiebaut-Bertrand, et al.
Journal of Hematotherapy & Stem Cell Research|September 11, 2003
A single intravenous infusion of apoptotic cells, an alternative cell-based therapy approach facilitating hematopoietic cell engraftment, did not induce autoimmunitySylvain Perruche, François Kleinclauss, Régis Angonin, et al.
Fundamental & Clinical Pharmacology|October 12, 2018
Inflammation is a potential risk factor of voriconazole overdose in hematological patientsElodie Gautier-Veyret, Aurélie Truffot, Sébastien Bailly, et al.
Transplantation|November 20, 2002
Factor XIII replacement in stem-cell transplant recipients with severe hemorrhagic cystitis: a report of four casesKarine Demesmay, Edgar Tissot, Claude-Eric Bulabois, et al.
Experimental Hematology|October 8, 2008
Proteomic study of the impact of the JAK2-V617F mutation on the phenotype of essential thrombocythemiaPascal Mossuz, Marie Arlotto, Sylvie Hermouet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
Quantitating effector and regulatory T lymphocytes in immune responses by limiting dilution analysis modelingThierry Bonnefoix, Philippe Bonnefoix, Pascal Perron, et al.
Bulletin Du Cancer|August 29, 2006
[Cost of hospital-based management of acute myeloid leukemia: from analytical to procedure-based tarification]Philippe Fagnoni, Samuel Limat, Estelle Hintzy-Fein, et al.
Clinical Drug Investigation|May 30, 2007
Cost Effectiveness of Cardioprotective Strategies in Patients with Aggressive Non-Hodgkin's LymphomaSamuel Limat, Karine Demesmay, Philippe Fagnoni, et al.
Pageof 17